Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01520311Not ApplicableTerminated

The eSVS® Mesh Post-Marketing Trial

Role: lead

NCT01676376Phase 1Unknown

The eMESH 1 Feasibility Study

Role: lead

NCT01462721Not ApplicableTerminated

The eSVS® Mesh Randomized Post-Market Study

Role: lead

NCT00777777Phase 2Unknown

The eSVS (TM) Mesh External Saphenous Vein Support Trial

Role: collaborator

All 4 trials loaded